1-Benzyl 4-(tert-butyl) (2R,5R)-2-(hydroxymethyl)-5-methylpiperazine-1,4-dicarboxylate, 98%, 100mg

ethyl 2-hydroxy-4-oxo-4-[3-(trifluoromethyl)phenyl]but-2-enoate, 95%, 50mg

N-Butyl-2-cyano-acetamide, 95.0%, 1g

4-(2-Chloroacetyl)benzonitrile, 95%, 250mg

Mortiers avec pilon forme haute, 100 ml, Hauteur, 56 mm, 1 Set

(2R,3R)-3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2-methyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 1g

2-(5-Methyl-furan-2-yl)-4-(3-nitro-phenyl)-6-phenyl-pyridine, 1mg

6-Chloro-3-hydroxypyrazine-2-carboxamide, 95.0%, 250mg

(3-(Pent-4-ynamido)phenyl)boronic acid, 98%, 250mg

G0F 2AB (500pmol/vial)1vial

(4-((2,6-Diisopropylphenoxy)methyl)phenyl)boronic acid, 95%, 250mg

8-Chloro-3,4-dihydro-2h-1,4-benzoxazine, 98+%, 250mg

3-Cyano-3,3-dimethylpropanoic acid, 97%, 250mg